This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Garcha, R. S Articles by Hughes, A. D Search for Related Content PubMed PubMed Citation Articles by Garcha, R. S Articles by Hughes, A. D Social Bookmarking                         What's this?

CNP, but not ANP or BNP, Relax Human Isolated Subcutaneous Resistance Arteries by an Action Involving Cyclic GMP and BKCa Channels

Clinical Pharmacology, National Heart & Lung Institute, Faculty of Medicine, Imperial College London, W2 1NY, UK

Alun D Hughes

Clinical Pharmacology, National Heart & Lung Institute, Faculty of Medicine, Imperial College London, W2 1NY, UK, a.hughes{at}imperial.ac.uk

Natriuretic peptides play an important role in sodium regulation and blood pressure (BP) control. We examined the effects of atrial natriuetic peptide (ANP), brain natriuretic peptide (BNP) and C-type natriuretic peptide (CNP) on human isolated resistance arteries and the mechanisms involved in vasorelaxation. Human subcutaneous resistance arteries were mounted in an isometric myograph and contracted with phenylephrine. CNP, but not ANP or BNP, relaxed arteries in a concentration dependent manner. The action of CNP was unaffected by removal of the endothelium, inhibition of nitric oxide synthase by NG-monomethyl-Larginine or inhibition of soluble guanylate cyclase by 1H-[1,2,4] oxadiazolo [4,3-alpha] quinoxalin-1-one. Blockade of cyclic GMP-dependent kinase by 8- bromoguanosine-3', 5'- cyclic monophosphorothioate, Rp-isomer (Rp-8-Br-cGMPS) inhibited CNP relaxation. CNP relaxation was also inhibited by high potassium or iberiotoxin, indicating that it was due to opening of BK_Ca channels. Omapatrilat, a vasopeptidase inhibitor of neutral endopeptidase and angiotensin-converting enzyme, enhanced the effect of CNP and inhibited responses to Ang I. In summary, CNP, but not ANP or BNP, relaxes human resistance arteries by activating cyclic GMP-dependent kinase and BK_Ca. The effects of CNP are enhanced by vasopeptidase inhibition and this may contribute to the vasodilator effects of these agents in vivo. Since CNP is widely present in endothelium it may play a role in the regulation of peripheral resistance in man in physiological and pathological circumstances.

Key Words: Natriuretic peptides • ANP • BNP • CNP • Omapatrilat • Neutral endopeptidase • Ca2+-activated potassium channels • Cyclic GMP

References

• Pandey KN Biology of natriuretic peptides and their receptors. Peptides 2005;26(6):901-32.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Sagnella GA Practical implications of current natriuretic peptide research. JRAAS 2000;1(4):304-15.[Medline] [Order article via Infotrieve]
• Shen YT, Graham RM, Vatner SF Effects of atrial natriuretic factor on blood flow distribution and vascular resistance in conscious dogs. Am J Physiol 1991;260(6 Pt 2):H1893-H1902.[Web of Science][Medline] [Order article via Infotrieve]
• Roques BP, Noble F., Dauge V., Fournie-Zaluski MC, Beaumont A. Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology. Pharmacol Rev 1993;45(1):87-146.[Web of Science][Medline] [Order article via Infotrieve]
• Fink CA, Carlson JE, McTaggart PA et al. Mercaptoacyl dipeptides as orally active dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase. J Med Chem 1996;39(16):3158-68.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Kostis JB, Packer M., Black HR, Schmieder R., Henry D., Levy E. Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment versus Enalapril (OCTAVE) trial. Am J Hypertens 2004;17(2):103-11.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Hughes A., Thom S., Goldberg P., Martin G., Sever P. Direct effect of -human atrial natriuretic peptide on human vasculature in vivo and in vitro. Clin Sci 1988;74:207-11.[Web of Science][Medline] [Order article via Infotrieve]
• van der ZK, Houben AJ, Kroon AA, De Leeuw PW Effects of brain natriuretic peptide on forearm vasculature: comparison with atrial natriuretic peptide. CardiovascRes 1999; 44(3):595-600.[Abstract/Free Full Text]
• Nakamura M., Arakawa N., Yoshida H., Makita S., Hiramori K. Vasodilatory effects of C-type natriuretic peptide on forearm resistance vessels are distinct from those of atrial natriuretic peptide in chronic heart failure. Circulation 1994; 90(3):1210-14.[Abstract/Free Full Text]
• Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 1977;41:19-26.[Free Full Text]
• Prieto D., Benedito S., Nyborg NC Heterogeneous involvement of endothelium in calcitonin gene-related peptide-induced relaxation in coronary arteries from rat. Br J Pharmacol 1991;103(3):1764-8.[Web of Science][Medline] [Order article via Infotrieve]
• Simonsen U., Wadsworth RM, Buus NH, Mulvany MJ In vitro simultaneous measurements of relaxation and nitric oxide concentration in rat superior mesenteric artery. J Physiol (Lond) 1999;516(Pt 1):271-82.[Abstract/Free Full Text]
• Buus NH, Simonsen U., Pilegaard HK, Mulvany MJ Nitric oxide, prostanoid and non-NO, non-prostanoid involvement in acetylcholine relaxation of isolated human small arteries. Br J Pharmacol 2000;129(1):184-92.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Schrammel A., Behrends S., Schmidt K., Koesling D., Mayer B. Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase. Mol Pharmacol 1996;50(1):1-5.[Abstract]
• Hughes AD, Nielsen H., Sever PS The effect of atrial natriuretic peptide on human isolated resistance arteries. Br J Pharmacol 1989;97:1027-30.[Web of Science][Medline] [Order article via Infotrieve]
• Honing ML, Smits P., Morrison PJ, Burnett JC, Jr., Rabelink TJ C-type natriuretic peptide-induced vasodilation is dependent on hyperpolarization in human forearm resistance vessels. Hypertens 2001;37(4):1179-83.[Abstract/Free Full Text]
• Chauhan SD, Nilsson H., Ahluwalia A., Hobbs AJ Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor. Proc Natl Acad Sci USA 2003;100(3):1426-31.[Abstract/Free Full Text]
• Intengan HD, Schiffrin EL Vasopeptidase inhibition has potent effects on blood pressure and resistance arteries in stroke-prone spontaneously hypertensive rats. Hypertens 2000;35(6):1221-5.[Abstract/Free Full Text]
• d'Uscio LV, Quaschning T., Burnett JC, Jr., Luscher TF Vasopeptidase Inhibition Prevents Endothelial Dysfunction of Resistance Arteries in Salt-Sensitive Hypertension in Comparison With Single ACE Inhibition. Hypertens 2001;37(1):28-33.[Abstract/Free Full Text]
• Cargill RI, Barr CS, Coutie WJ, Struthers AD, Lipworth BJ C-type natriuretic peptide levels in cor pulmonale and in congestive heart failure. Thorax 1994;49(12):1247-9.[Abstract/Free Full Text]
• Hama N., Itoh H., Shirakami G., Suga S., Komatsu Y., Yoshimasa T., Tanaka I., Mori K., Nakao K. Detection of C-type natriuretic peptide in human circulation and marked increase of plasma CNP level in septic shock patients. Biochem Biophys Res Commun 1994;198(3):1177-82.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Buckley MG, Markandu ND, Miller MA, Sagnella GA, MacGregor GA Plasma concentrations and comparisons of brain and atrial natriuretic peptide in normal subjects and in patients with essential hypertension. J Hum Hypertens 1993;7(3):245-50.[Web of Science][Medline] [Order article via Infotrieve]
• Cheung BM, Brown MJ Plasma brain natriuretic peptide and C-type natriuretic peptide in essential hypertension. J Hypertens 1994;12(4):449-54.[Web of Science][Medline] [Order article via Infotrieve]

Journal of Renin-Angiotensin-Aldosterone System, Vol. 7, No. 2, 87-91 (2006)
DOI: 10.3317/jraas.2006.014


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				A. Simon, E. O. Harrington, G. X. Liu, G. Koren, and G. Choudhary Mechanism of C-type natriuretic peptide-induced endothelial cell hyperpolarization Am J Physiol Lung Cell Mol Physiol, February 1, 2009; 296(2): L248 - L256. [Abstract] [Full Text] [PDF]

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Garcha, R. S Articles by Hughes, A. D Search for Related Content PubMed PubMed Citation Articles by Garcha, R. S Articles by Hughes, A. D Social Bookmarking                         What's this?